Research Articles
Research articles concerning NAFLD are extracted from PubMed. For each individual article, related therapeutic strategies, targets, drugs and associated diseases in NAFLDkb are presented with knowledge graphs.
stats1
stats2
stats3
stats4
Search for:
Obesity11722 records.
| Article ID | PMID | Source | Title | Publish Year | |
|---|---|---|---|---|---|
| A12085 | 30609187 | Liver Transpl | Increasing Incidence of Nonalcoholic Steatohepatitis as an Indication for Liver Transplantation in Australia and New Zealand. | 2019 | Details |
| A12086 | 30608932 | PLoS One | High prevalence of nonalcoholic steatohepatitis and abnormal liver stiffness in a young and obese Mexican population. | 2019 | Details |
| A12089 | 30606929 | Yakugaku Zasshi | [A Multifaceted Approach regarding the Association of the DsbA-L Gene with the Risk of Obesity-related Diseases Based on Clinical Pharmacogenetics]. | 2019 | Details |
| A12090 | 30606928 | Yakugaku Zasshi | [The Investigation of Genes, Using an Improved Adenovirus Vector, and Food for the Treatment and Prevention of Type 2 Diabetes Mellitus]. | 2019 | Details |
| A12093 | 30605818 | Environ Pollut | Effects of triphenyl phosphate exposure during fetal development on obesity and metabolic dysfunctions in adult mice: Impaired lipid metabolism and intestinal dysbiosis. | 2018 | Details |
| A12094 | 30605676 | Cell Rep | Genetic Liver-Specific AMPK Activation Protects against Diet-Induced Obesity and NAFLD. | 2019 | Details |
| A12101 | 30602382 | J Transl Med | Interferon-alpha 2 but not Interferon-gamma serum levels are associated with intramuscular fat in obese patients with nonalcoholic fatty liver disease. | 2019 | Details |
| A12103 | 30601174 | Curr Opin Clin Nutr Metab Care | Omega-3 fatty acids and nonalcoholic fatty liver disease in adults and children: where do we stand? | 2019 | Details |
| A12107 | 30600295 | Ann Hepatol | Association of Parity in Patients with Chronic Liver Disease. | 2018 | Details |
| A12108 | 30599260 | Free Radic Biol Med | Loss of RIP3 initiates annihilation of high-fat diet initialized nonalcoholic hepatosteatosis: A mechanism involving Toll-like receptor 4 and oxidative stress. | 2018 | Details |
| A12110 | 30598254 | Surg Obes Relat Dis | Gastric bypass specifically impairs liver parameters as compared with sleeve gastrectomy, independently of evolution of metabolic disorders. | 2018 | Details |
| A12111 | 30597715 | Liver Int | Prevalence and outcomes of non-alcoholic fatty liver disease (NAFLD) among Asian American adults in the United States. | 2019 | Details |
| A12114 | 30596786 | PLoS One | Protective effects of Bacillus probiotics against high-fat diet-induced metabolic disorders in mice. | 2018 | Details |
| A12119 | 32422008 | Crit Rev Eukaryot Gene Expr | Current Update on Preclinical and Clinical Studies of Resveratrol, a Naturally Occurring Phenolic Compound. | 2020 | Details |
| A12120 | 32146799 | Pol J Pathol | Green tea extract prevents the development of nonalcoholic liver steatosis in rats fed a high-fat diet. | 2019 | Details |
| A12121 | 30594638 | Biochim Biophys Acta Gene Regul Mech | Role of long non-coding RNAs in metabolic control. | 2018 | Details |
| A12126 | 30591521 | EMBO Mol Med | The role of the microbiome in NAFLD and NASH. | 2019 | Details |
| A12127 | 30590942 | Vnitr Lek | Fatty pancreas disease: clinical impact. | 2019 | Details |
| A12129 | 30590868 | J Gastroenterol Hepatol | Characteristics of non-alcoholic steatohepatitis among lean patients in Japan: Not uncommon and not always benign. | 2019 | Details |
| A12133 | 30589487 | Obes Rev | Crosstalk between nonalcoholic fatty liver disease and cardiometabolic syndrome. | 2018 | Details |
| A12135 | 30588564 | Drugs | Current and Emerging Therapies for Non-alcoholic Fatty Liver Disease. | 2019 | Details |
| A12136 | 30588203 | Int J Med Sci | No Evidence for Lower Levels of Serum Vitamin D in the Presence of Hepatic Steatosis. A Study on the Portuguese General Population. | 2018 | Details |
| A12137 | 30588181 | Int J Med Sci | Phenotypic Alteration of Hepatocytes in Non-Alcoholic Fatty Liver Disease. | 2018 | Details |
| A12138 | 30588150 | Pediatric Health Med Ther | Interventions to improve liver enzyme screening testing in obese patients aged <18 years in a public hospital, Chicago, IL, 2017-2018. | 2018 | Details |
| A12140 | 30585337 | J Clin Pharm Ther | The effect of alpha-lipoic acid on inflammatory markers and body composition in obese patients with non-alcoholic fatty liver disease: A randomized, double-blind, placebo-controlled trial. | 2018 | Details |
| A12143 | 30583863 | Biochem Biophys Res Commun | Erythropoietin and long-acting erythropoiesis stimulating agent ameliorate non-alcoholic fatty liver disease by increasing lipolysis and decreasing lipogenesis via EPOR/STAT pathway. | 2018 | Details |
| A12147 | 30582764 | Hepatology | Dual-Specificity Phosphatase 26 Protects Against Nonalcoholic Fatty Liver Disease in Mice Through Transforming Growth Factor Beta-Activated Kinase 1 Suppression. | 2019 | Details |
| A12148 | 30582669 | Hepatology | The Role of Three-Dimensional Magnetic Resonance Elastography in the Diagnosis of Nonalcoholic Steatohepatitis in Obese Patients Undergoing Bariatric Surgery. | 2019 | Details |
| A12154 | 30580090 | Clin Gastroenterol Hepatol | Health-related Quality of Life in Nonalcoholic Fatty Liver Disease Associates With Hepatic Inflammation. | 2018 | Details |
| A12159 | 30578461 | Adv Exp Med Biol | Fighting Fatty Liver Diseases with Nutritional Interventions, Probiotics, Symbiotics, and Fecal Microbiota Transplantation (FMT). | 2019 | Details |
| A12163 | 30577415 | Int J Mol Sci | Diet-Independent Correlations between Bacteria and Dysfunction of Gut, Adipose Tissue, and Liver: A Comprehensive Microbiota Analysis in Feces and Mucosa of the Ileum and Colon in Obese Mice with NAFLD. | 2018 | Details |
| A12166 | 30576769 | Cell Mol Gastroenterol Hepatol | Targeted Delivery of Stk25 Antisense Oligonucleotides to Hepatocytes Protects Mice Against Nonalcoholic Fatty Liver Disease. | 2018 | Details |
| A12167 | 30576688 | Metabolism | Surgical management of obesity. | 2018 | Details |
| A12168 | 30576537 | Hum Reprod | Features of the metabolic syndrome in late adolescence are associated with impaired testicular function at 20 years of age. | 2019 | Details |
| A12169 | 30576354 | PLoS One | Measurement of liver iron by magnetic resonance imaging in the UK Biobank population. | 2018 | Details |
| A12171 | 30576244 | Am J Physiol Endocrinol Metab | Repeated clodronate-liposome treatment results in neutrophilia and is not effective in limiting obesity-linked metabolic impairments. | 2018 | Details |
| A12174 | 30574460 | Eur Thyroid J | Association between Thyroid-Stimulating Hormone Levels and Non-Alcoholic Fatty Liver Disease Is Not Independent from Metabolic Syndrome Criteria. | 2018 | Details |
| A12180 | 30573307 | Nutr Metab Cardiovasc Dis | High prevalence of non-alcoholic fatty liver disease and metabolic risk factors in Guatemala: A population-based study. | 2018 | Details |
| A12182 | 30572788 | Biosci Biotechnol Biochem | A review of the studies on food-derived factors which regulate energy metabolism via the modulation of lipid-sensing nuclear receptors. | 2018 | Details |
| A12187 | 30569636 | Obesity (Silver Spring) | Blackcurrant (Ribes nigrum) Prevents Obesity-Induced Nonalcoholic Steatohepatitis in Mice. | 2019 | Details |
| A12195 | 30567368 | Int J Mol Sci | Effective Food Ingredients for Fatty Liver: Soy Protein β-Conglycinin and Fish Oil. | 2018 | Details |
| A12202 | 30563997 | J Clin Exp Hepatol | Biopsy Proven Fibrosis in Non-Alcoholic Fatty Liver Disease: An Analysis of Risk Factors. | 2018 | Details |
| A12205 | 30562976 | J Clin Med | Lean Patients with Non-Alcoholic Fatty Liver Disease Have a Severe Histological Phenotype Similar to Obese Patients. | 2018 | Details |
| A12206 | 30562559 | Biochim Biophys Acta Mol Basis Dis | Hepatic mTOR-AKT2-Insig2 signaling pathway contributes to the improvement of hepatic steatosis after Roux-en-Y Gastric Bypass in mice. | 2018 | Details |
| A12208 | 30561273 | Radiology | Monitoring Fatty Liver Disease with MRI Following Bariatric Surgery: A Prospective, Dual-Center Study. | 2018 | Details |
| A12210 | 30561027 | Aliment Pharmacol Ther | Impact of a structured lifestyle programme on patients with metabolic syndrome complicated by non-alcoholic fatty liver disease. | 2018 | Details |
| A12217 | 30559024 | J Pediatr | Prevalence of Nonalcoholic Fatty Liver Disease in Children with Obesity. | 2018 | Details |
| A12224 | 30556038 | Hepatol Commun | Perinatal Nutritional Reprogramming of the Epigenome Promotes Subsequent Development of Nonalcoholic Steatohepatitis. | 2018 | Details |
| A12225 | 30556037 | Hepatol Commun | Inhibition of Plasminogen Activator Inhibitor 1 Attenuates Hepatic Steatosis but Does Not Prevent Progressive Nonalcoholic Steatohepatitis in Mice. | 2018 | Details |
| A12231 | 30554783 | Lancet | Pegbelfermin (BMS-986036), a PEGylated fibroblast growth factor 21 analogue, in patients with non-alcoholic steatohepatitis: a randomised, double-blind, placebo-controlled, phase 2a trial. | 2018 | Details |
| A12232 | 30554468 | Liver Int | Serum adipocyte fatty acid-binding protein levels: An indicator of non-alcoholic fatty liver disease in Chinese individuals. | 2018 | Details |
| A12237 | 30551665 | Children (Basel) | Pediatric Fatty Liver and Obesity: Not Always Justa Matter of Non-Alcoholic Fatty Liver Disease. | 2018 | Details |
| A12238 | 30551613 | Nutrients | Trimethylamine-N-oxide (TMAO) as Novel Potential Biomarker of Early Predictors of Metabolic Syndrome. | 2018 | Details |
| A12242 | 30551263 | J Gastroenterol Hepatol | Screening for non-alcoholic fatty liver disease in patients with type 2 diabetes mellitus using transient elastography. | 2019 | Details |
| A12248 | 30547890 | Eur Cytokine Netw | Obesity and inflammation. | 2018 | Details |
| A12250 | 30547371 | Adv Ther | Understanding Patient Preferences and Unmet Needs in Non-alcoholic Steatohepatitis (NASH): Insights from a Qualitative Online Bulletin Board Study. | 2018 | Details |
| A12254 | 30545385 | Lipids Health Dis | Atherogenic index of plasma is a novel predictor of non-alcoholic fatty liver disease in obese participants: a cross-sectional study. | 2018 | Details |
| A12260 | 30542827 | Obes Surg | Long-term Results of Bariatric Surgery for Non-alcoholic Fatty Liver Disease/Non-alcoholic Steatohepatitis Treatment in Morbidly Obese Japanese Patients. | 2019 | Details |
| A12263 | 30523118 | Proc Natl Acad Sci U S A | Modulation of HIF-2α PAS-B domain contributes to physiological responses. | 2018 | Details |
| A12266 | 30541128 | J Clin Endocrinol Metab | The Gly385(388)Arg Polymorphism of the FGFR4 Receptor Regulates Hepatic Lipogenesis Under Healthy Diet. | 2019 | Details |
| A12267 | 30541001 | Ann Nutr Metab | Association of Circulating Adipsin, Visfatin, and Adiponectin with Nonalcoholic Fatty Liver Disease in Adults: A Case-Control Study. | 2018 | Details |
| A12270 | 30540086 | Arq Gastroenterol | CORRELATION BETWEEN NONALCOHOLIC FATTY LIVER DISEASE FEATURES AND LEVELS OF ADIPOKINES AND INFLAMMATORY CYTOKINES AMONG MORBIDLY OBESE INDIVIDUALS. | 2019 | Details |
| A12272 | 30539516 | Hepatol Int | Lean non-alcoholic fatty liver disease (lean NAFLD): characteristics, metabolic outcomes and risk factors from a 7-year prospective, community cohort study from Sri Lanka. | 2018 | Details |
| A12275 | 30537758 | Digestion | Nonalcoholic-Fatty-Liver-Disease and Nonalcoholic Steatohepatitis: Successful Development of Pharmacological Treatment Will Depend on Translational Research. | 2018 | Details |
| A12278 | 30537110 | Mol Nutr Food Res | Combination of Whole Grapeseed Flour and Newly Isolated Kefir Lactic Acid Bacteria Reduces High-Fat-Induced Hepatic Steatosis. | 2018 | Details |
| A12279 | 30536914 | J Physiol | Perilipin-2 promotes obesity and progressive fatty liver disease in mice through mechanistically distinct hepatocyte and extra-hepatocyte actions. | 2019 | Details |
| A12284 | 30533221 | J Obes | Weight Loss Induced by Bariatric Surgery Restricts Hepatic GDF15 Expression. | 2018 | Details |
| A12289 | 30528710 | Dig Liver Dis | Salivary markers of hepato-metabolic comorbidities in pediatric obesity. | 2018 | Details |
| A12293 | 30526624 | J Transl Med | L-Fucose ameliorates high-fat diet-induced obesity and hepatic steatosis in mice. | 2018 | Details |
| A12297 | 30520566 | Obesity (Silver Spring) | Pegbelfermin (BMS-986036), PEGylated FGF21, in Patients with Obesity and Type 2 Diabetes: Results from a Randomized Phase 2 Study. | 2018 | Details |
| A12304 | 30508523 | Biochem Pharmacol | Targeting mitochondria to oppose the progression of nonalcoholic fatty liver disease. | 2018 | Details |
| A12309 | 30505829 | Front Pediatr | Is There an Association of Vascular Disease and Atherosclerosis in Children and Adolescents With Obesity and Non-alcoholic Fatty Liver Disease? | 2018 | Details |
| A12313 | 30502373 | Metabolism | Obesity and nonalcoholic fatty liver disease: From pathophysiology to therapeutics. | 2018 | Details |
| A12317 | 30516845 | Hepatology | Thioesterase Superfamily Member 2 Promotes Hepatic VLDL Secretion by Channeling Fatty Acids Into Triglyceride Biosynthesis. | 2019 | Details |
| A12320 | 30516498 | Georgian Med News | EFFECTIVENESS OF NONALCOHOLIC STEATOHEPATITIS CORRECTION ON THE BAСKGROUND OF OBESITY WITH CONCOMITANT CHRONIC KIDNEY DISEASE. | 2018 | Details |
| A12324 | 30515622 | Obes Surg | Improvement in Non-alcoholic Fatty Liver Disease Score Correlates with Weight Loss in Obese Patients Undergoing Laparoscopic Sleeve Gastrectomy: a Two-Centre Study from an Asian Cohort. | 2019 | Details |
| A12330 | 30512987 | Am J Physiol Endocrinol Metab | Estrogen receptor-α signaling maintains immunometabolic function in males and is obligatory for exercise-induced amelioration of nonalcoholic fatty liver. | 2018 | Details |
| A12331 | 30511955 | J Musculoskelet Neuronal Interact | Can obesity-induced inflammation in skeletal muscle and intramuscular adipose tissue accurately detect liver fibrosis? | 2018 | Details |
| A12336 | 30509561 | J Formos Med Assoc | Gut microbiota and pediatric obesity/non-alcoholic fatty liver disease. | 2018 | Details |
| A12337 | 30509175 | BMC Genomics | Corn dried distillers grains with solubles (cDDGS) in the diet of pigs change the expression of adipose genes that are potential therapeutic targets in metabolic and cardiovascular diseases. | 2018 | Details |
| A12344 | 30498904 | J Gastroenterol | A nationwide survey on non-B, non-C hepatocellular carcinoma in Japan: 2011-2015 update. | 2018 | Details |
| A12348 | 30496690 | Postgrad Med | Clinical workup of fatty liver for the primary care provider. | 2018 | Details |
| A12349 | 30496542 | J Clin Endocrinol Metab | Sex Hormone-Binding Globulin Expression Correlates With Acetyl-Coenzyme A Carboxylase and Triglyceride Content in Human Liver. | 2019 | Details |
| A12350 | 30495974 | Am J Physiol Gastrointest Liver Physiol | Factors influencing longitudinal changes of circulating liver enzyme concentrations in subjects randomized to placebo in four clinical trials. | 2018 | Details |
| A12356 | 30488259 | Obes Surg | A Pilot Study of Serum Sphingomyelin Dynamics in Subjects with Severe Obesity and Non-alcoholic Steatohepatitis after Sleeve Gastrectomy. | 2019 | Details |
| A12359 | 30487357 | Exp Anim | AIM-deficient mouse fed a high-trans fat, high-cholesterol diet: a new animal model for nonalcoholic fatty liver disease. | 2018 | Details |
| A12366 | 30483595 | JGH Open | Epidemiology of non-alcoholic fatty liver disease-related hepatocellular carcinoma and its implications. | 2018 | Details |
| A12367 | 30483565 | JGH Open | Is non-alcoholic fatty liver disease a reflection of what we eat or simply how much we eat? | 2018 | Details |
| A12369 | 30483562 | JGH Open | Prevalence and risk factors of non-alcoholic fatty liver disease in Bangladesh. | 2018 | Details |
| A12372 | 30483219 | Front Endocrinol (Lausanne) | Comparison of the Prevalence of Metabolic Disease Between Two Types of Urbanization in China. | 2018 | Details |
| A12377 | 30479664 | Therap Adv Gastroenterol | Advances and challenges in the management of advanced fibrosis in nonalcoholic steatohepatitis. | 2018 | Details |
| A12379 | 30477455 | BMC Endocr Disord | Treatment with PBI-4050 in patients with Alström syndrome: study protocol for a phase 2, single-Centre, single-arm, open-label trial. | 2018 | Details |
| A12383 | 30474798 | J Endocrinol Invest | Periostin concentrations in childhood-onset craniopharyngioma patients. | 2018 | Details |
| A12384 | 30474288 | Obes Rev | Sarcopenia in patients with non-alcoholic fatty liver disease: is it a clinically significant entity? | 2018 | Details |
| A12389 | 30473364 | Lancet | Gathering momentum for the way ahead: fifth report of the Lancet Standing Commission on Liver Disease in the UK. | 2018 | Details |
| A12390 | 30473057 | Metabolism | Adiponectin homolog novel osmotin protects obesity/diabetes-induced NAFLD by upregulating AdipoRs/PPARα signaling in ob/ob and db/db transgenic mouse models. | 2018 | Details |
| A12392 | 30472977 | J Pharm Pharm Sci | Non-alcoholic Steatohepatitis (NASH) Drug Discovery - Building a Consensus on ADME Screening Tools and Clinical Pharmacology Strategies to Aid Candidate Development. | 2018 | Details |
| A12397 | 30472683 | Gut | Alcoholic and non-alcoholic fatty liver disease and associations with coronary artery calcification: evidence from the Kangbuk Samsung Health Study. | 2018 | Details |
| A12398 | 30472196 | Diabetes Metab | Low N-terminal pro-brain natriuretic peptide levels are associated with non-alcoholic fatty liver disease in patients with type 2 diabetes. | 2018 | Details |
| A12402 | 30470823 | Oncogene | Indian Hedgehog links obesity to development of hepatocellular carcinoma. | 2018 | Details |